Chemopreventive potential of diosgenin on modulating glycoproteins, TCA cycle enzymes, carbohydrate metabolising enzymes and biotransformation enzymes against N-methyl-N-nitrosourea induced mammary carcinogenesis

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 5, Issue 4, 2013, Pages 575-582

  Jagadeesan, A J ^a   Langeswaran, K ^a,b   Gowtham Kumar, S ^c   Revathy, R ^a   Balasubramanian, M P ^a  

^a UNIVERSITY OF MADRAS   (India)

^b BHARATH UNIVERSITY   (India)

^c CHETTINAD HOSPITAL AND RESEARCH INSTITUTE   (India)

Author keywords

Biotransformation enzymes; Breast cancer; Carbohydrate metabolising enzymes; Glycoproteins; Mammary cancer; TCA cycle enzymes

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (MAGNESIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DIOSGENIN; FRUCTOSE BISPHOSPHATASE; FRUCTOSE BISPHOSPHATE ALDOLASE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE ISOMERASE; GLYCOPROTEIN; HEXOKINASE; HEXOSAMINE; HEXOSE; ISOCITRATE DEHYDROGENASE; MALATE DEHYDROGENASE; METHYLNITROSOUREA; OXOGLUTARATE DEHYDROGENASE; SAPOGENIN; SIALIC ACID; SUCCINATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOTRANSFORMATION; BLOOD SAMPLING; BREAST CARCINOGENESIS; CARBOHYDRATE METABOLISM; CHEMICAL ANALYSIS; CHEMOPROPHYLAXIS; CITRIC ACID CYCLE; CONTROLLED STUDY; FEMALE; NONHUMAN; RAT;

EID: 84885349833     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (84)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: a cancer journal for clinicians 2011; 61(2): 69-90.
2. Qing E Tian, Huan De Li, Miao Yan, Hua-Lin Cai, Qin-You Tan, Wen-Yuan Zhang. Astragalus polysaccharides on P-glycoprotein efflux pump function and protein expression in H22 hepatoma cells in vitro. World J Gastroenterol 2012; 18(47): 7079-7086.
3. Sariego J. Breast cancer in the young patient. The American surgeon 2010; 76(12): 1397-1401.
4. Krishnan P, Yan KJ, Windler D, Tubbs J, Grand R, Li BD, Aldaz CM, McLarty J, Kleiner-Hancock HE. Citrusauraptene suppresses cyclin D1 and significantly delays N-methyl nitrosourea induced mammary carcinogenesis in female Sprague Dawley rats. BMC Cancer 2009; 9(259): 1-12.
5. Weiss RH, Marshall D, Howard L, Corbacho AM, Cheung AT, Sawai ET. Suppression of breast cancer growth and angiogenesis by an antisense oligodeoxynucleotide to p21. Cancer Lett 2003; 189(1): 39-48.
6. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18(3): 581-592.
7. Florescu A, Amir E, Bouganim N, Clemons M. Immune therapy for breast cancer in 2010-hype or hope? Current Oncology 2011; 18(1): 9-18.
8. Vargo-Gogola T, Rosen JM. Modelling breast cancer: one size does not fit all. Nature Reviews 2007; 7(9): 659-672.
9. McPherson K, Steel CM, Dixon JM. Breast cancer epidemiology, risk factors, and genetics. Br Med J 2000; 321: 624-628.
10. Carter RF. BRCA1, BRCA2 and breast cancer: a concise clinical review. Clin Invest Med 2001; 24(3): 147-157.
11. Nandakumar N, Haribabu L, Perumal S, Balasubramanian MP. Therapeutic effect of hesperidin with reference to biotransformation, lysosomal and mitochondrial TCA cycle enzymes against 7, 12-dimethylbenz(a)anthracene-induced experimental mammary cellular carcinoma. Biomedicine & Aging Pathology 2011; 1: 158-168.
12. Gullino PM, Pettigrew HM, Grantham FH. N-nitrosomethylurea as mammary gland carcinogen in rats. J Natl Cancer Inst 1975; 54(2): 401-414.
13. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, van Zwieten MJ. Comparative study of human and rat mammary tumorigenesis. Lab Invest 1990; 62: 244-278.
14. Martin G, Davio C, Rivera E, Melito G, Cricco G, Andrade N, Caro D, Bergoc R. Hormone dependence of mammary tumors induced in rats by intraperitoneal NMU injection. Cancer Invest 1997; 15: 8-17.
15. Nandi S, Guzman RC, Yang J. Hormones and mammary carcinogenesis in mice, rats and humans: A unifying hypothesis. Proc Natl Acad Sci USA 1995; 92: 3650-3657.
16. Duss S, André S, Nicoulaz AL, Fiche M, Bonnefoi H, Brisken C, Iggo RD. An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells. Breast Cancer Res 2007; 9(3): 1-15.
17. Vijayaprakash S, Langeswaran K, Jagadeesan AJ, Rveathy R, Balasubramanian MP. Protective efficacy of Terminalia catappa L. Leaves against lead induced nephrotoxicity in experimental rats. Int J Pharm Pharm Sci 2012; 4(Suppl 3): 454-458.
18. Wattenberg LW. Chemoprevention of cancer by naturally occurring and synthetic compounds. In: Wattenberg LW, Lipkin M, Boone CW, Kellof GJ, editors. Cancer chemoprevention. Boca Raton: CRC Press; 1985. p. 19-39.
19. Huang MT, Wood AW, Newmark HL, Sayer JM, Yagi H, Jerina DM, Conney AH. Inhibition of the mutagenicity of bay-region diol-epoxides of polycyclic aromatic hydrocarbons by phenolic plant flavonoids. Carcinogenesis 1983; 4(12): 1631-1637.
20. Kwon KH, Barve A, Yu S, Huang MT, Kong ANT. Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models. Acta Pharmacol Sin 2007; 28(9): 1409-1421.
21. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999; 58(11): 1685-93.
22. 2+ homeostasis. Cancer Chemother Pharmacol 2005; 55(1): 79-90.
23. Cayen MN, Dvornik D. Effect of diosgenin on lipid metabolism in rats. J Lipid Res 1979; 20(2): 162-74.
24. Ikeda T, Ando J, Miyazono A, Zhu XH, Tsumagari H, Nohara T, Yokomizo K, Uyeda M. Anti-herpes virus activity of Solanum steroidal glycosides. Biol Pharm Bull 2000; 23(3): 363-4.
25. Hufford CD, Liu SC, Clark AM. Antifungal activity of Trillium grandiflorum constituents. J Nat Prod 1988; 51(1): 94-98.
26. Ribes G, Sauvaire Y, Da Costa C, Baccou JC. Antidiabetic effects of subfractions from fenugreek seeds indiabetic dogs. Proc Soc Exp Biol Med 1986; 182: 159-166.
27. Raju J, Patlolla JM, Swamy MV, Rao CV. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and in duces apoptosis in HT-29 human colon cancer cells. Cancer Epidemiol Biomar Prev 2004; 13: 1392-1398.
28. Roman ID, Thewles A, Coleman R. Fractionation of livers following diosgenin treatment to elevate biliary cholesterol. Biochim Biophys Acta 1995; 1255: 77-81.
29. Wang SL, Cai B, Cui CB, Liu HW, Wu CF, Yao XS. Diosgenin-3-Oalpha-L-rhamnopyranosyl-(14)-beta-D-glucopyranoside obtained as a new anticancer agent from Dioscorea futschauensis induces apoptosis on human colon carcinoma HCT-15 cells via mitochondria-controlled apoptotic pathway. J Asian Nat Prod Res 2004; 6: 115-125.
30. Corbiere C, Liagre B, Bianchi A, Bordji K, Dauca M, Netter P, Beneytout JL. Different contribution of apoptosis to the antiproliferative effects of diosgenin and other plant steroids, hecogenin and tigogenin, on human 1547 osteosarcoma cells. Int J Oncol 2003; 22: 899-905.
31. 2+ homeostasis. Cancer Chemother Pharmacol 2005; 55: 79-90.
32. Niebes P. Determination of enzymes and degradation products of glycosamino glycan metabolism in the serum of healthy and various subjects. Clin Chem Acta 1972; 42: 399-408.
33. Wagner WD. A more sensitive assay discriminating galactosamine and glucosamine in mixtures. Anal Biochem 1979; 94: 394-396.
34. Warren J. The thiobarbituric acid assay of sialic acid. J Biol Chem 1959; 234: 1971-1975.
35. Brandstrup N, Kirk JE, Bruni C. The hexokinase and phosphoglucoisomerase activities of aortic and pulmonary artery tissue in individuals of various ages. J Gerentol 1957; 12: 166-171.
36. Horrocks JE, Ward J, King J. A routine method for the determination of phosphoglucose isomerase activity in body fluid. J Clin Pahtol 1963; 16: 248-251.
37. King J. The phosphohydrolysases-acid and alkaline phosphatases, In: Practical Clinical Enzymology, (Eds.) Van Nostrand Co Ltd, London; 1965b. p. 191-208.
38. Gancedo JM, Gancedo C. Fructose-1, 6-diphosphatase, phosphofructokinase and glucose-6-phosphate dehydrogenase. Proc Soc Expl Biol Med 1971; 106: 607-609.
39. Fiske CH, Subbarow Y. The colorimetric determination of phosphorus. J Biol Chem 1925; 66: 375-400.
40. Dodge JT, Mitchell C, Hanahan DJ. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys 1963; 100: 199-130.
41. Quist EE. Regulation of erythrocyte membrane shape by calcium ion. Biochem Biophys Res Commun 1980; 92: 631-637.
42. Bonting SL. Sodium-potassium activated adenosine triphosphatase and cation transport. In: Membranes and Ion Transport, (eds.) Bittar EE, Wiley-Interscience, London; 1970. p. 257-363.
43. 2+-ATPase from erythrocyte membranes. Biochem Biophys Acta 1983; 728: 281-288.
44. 2+-ATPase activities in normal, regenerating and malignant cells. Biochem Biophys Acta 1962; 684: 67-74.
45. King J. The phosphohydrolysases-acid and alkaline phosphatases, In: Practical Clinical Enzymology, (Eds.) Van Nostrand Co Ltd, London; 1: 1965b. p. 191-208.
46. Slater EC, Borner WD. The effect of fluoride on the succine oxidase system. Biochem J 1952; 52: 185-196.
47. Mehler AH, Kornberg A, Grisolia S, Ochoa S. The enzymatic mechanism of oxidation-reductions between malate or isocitrate and pyruvate. J Biol Chem 1948; 174: 961-977.
48. Reed LJ, Mukherjee BB. α-ketoglutarate dehydrogenase complex from Escherichia coli. In: Methods is Enzymology, Lowenstein JM. (ed.) Academic Press, New York; 13: 1969. p. 55-61.
49. Boyd MR, Burka LT. In vivo studies on the relationship between target organ alkylation and the pulmonary toxicity of a chemically reactive metabolite of 4-ipomeanol. J Pharmacol Exp Ther 1978; 207: 687-697.
50. 2+ with endoplasmic reticulum of rat liver. A standardized procedure for the isolation of rat liver microsomes. Anal Biochem 1972; 48: 53-61.
51. Omura T, Sato R. The carbon monoxide binding pigment of liver microsomes. J Biol Chem 1964; 239: 2370-2378.
52. Philips AH, Langdon RG. Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization and kinetic studies. J Biol Chem 1962; 237: 2652-2660.
53. Habig WH, Pabste MJ, Jakboy WB. Glutathione-s-transferase: the firest enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249: 7130-7139.
54. Isselbacher KJ, Dienstag JL. Carcinomas of the liver. In: Fauci AS, Braunwald E, Isselbacher KJ, et al, eds. Harrison's Principles of Internal Medicine. 14th ed. New York, McGraw-Hill; 1998. p. 579-80.
55. Hollman S, Touster O. Alterations in tissue levels of Urdine diphosphate-glucose dehydrogenase, Uridine diphosphate-glucuronic acid pyrophosphatase and glucuronyl transferase induced by substances influencing the production of ascorbic acid. Biochem Biophys Acta 1962; 62: 338-352.
56. Jensen ON, Estene J, Moller H. Renardcarin the European community and members state. Eur J Cancer 1990; 26: 1167-1256.
57. Bolt HM, Filser JG. Irreversible binding of chlorinated ethylenels to macromolecules. Environ Health Perspect 1977; 21: 107-112.
58. Hughes RC. Membrane glycoproteins. Butterworth, London, 1976. p: 114-134, 152-170.
59. Selvam S, Nagini S. Administration of the plasticizer di(englhexyl)phthalate alters glycoconjugate profile. Ind J Physiol Pharmocol 1995; 39: 252-254.
60. Schauer R. Sialic acids and their role as biological masks. Trends Biochem Sci 1985; 10: 357-360.
61. Wongkham S, Bhudhisawadi V, Chau-in S, Boonla C, Muisuk K, Kongkham S, Wongkham C. Clinical significance of serum total sialic acid in cholangiocarcinoma. Clin Chim Acta 2003; 327(1-2): 139-147.
62. Singhal A, Hakomori S. Molecular changes in carbohydrate antigens associated with cancer. Bioassays 1990; 12: 223-230.
63. Eigenbrodt E, Glossmann H. Glycolysis one of the keys to cancer? Trends Pharmacol Sci 1980; 1: 240-245.
64. Bannasch P, Mayer D, Hacker HJ. Hepatocellular glycogenesis and hepatocarcinogenesis. Biochim Biophys Acta 1980; 605: 217-245.
65. Parry DM, Pedersen PL. Intracellular localization and properties of particulate hexokinase in the Novikoff ascites tumour. Evidence for an outer mitochondrial membrane location. J Biol Chem 1983; 258: 10904-10912.
66. Campbell DM, King EJ. Serum phosphatases and glycolytic enzymes in cancer of the breast. Biochem J 1962; 82: 23-28.
67. Schamhart DHJ, Van De Poll K, van Wick R. Comparative studies of glucose metabolism in HTC, RLC, MH1C1 and Reuber H35 rat hepatoma cells. Cancer Res 1979; 39: 1051-1055.
68. Ortega AD, Arago MS, Sanchez DG, Cenizo LS, Willers I, Cuezva JM. Glucose avidity of carcinomas. Cancer Lett 2009; 276: 125-135.
69. Bioj B, Moreto RD, Fairs RN. Membrane lipid fatty acid and regulation of membrane bound enzymes. Biochem Biophys Acta 1973; 311: 67.
70. Stekhoren MA, Bonting SL. Transport ATPases: Properties and functions. Physiol Rev 1981; 61: 1-76.
71. Ohta Y, Kongo-Nishimura M, Hayashi T, Kishikawa T. Effect or Oren-gedoku-To (Huanglian-Jie-Du-Tang) extract on disruption of hepatic antioxidant defense system in rats treated with D-galactosamine. J Ethanopharmacol 2002; 94: 323-329.
72. Selvendiran K, Sakthisekaran D. Chemopreventive effect of piperine on modulating lipid peroxidation and membrane bound enzymes in benzo(a)pyrene induced lung carcinogenesis. Biomed Pharmacother 2004; 58: 264-277.
73. 2+-ATPase by activated oxygen through thiol and lipid dependent mechanisms. Biochem Biophys Acta 1986; 862: 8-16.
74. Rauchova H, Ledvinkova J, Kalous M, Drahots Z. The effects of lipif peroxidation on the activity of various membrance bound ATPase in rat kidney. Int J Biochem Cell Biol 1995; 27: 251-255.
75. Padma P, Setty OH. Effect of administration of galactosamine hydrochloride on rat liver mitochondria. Ind J Biochem Biophy 1997; 34(3): 296-301.
76. Perumal S, Shanthi P, Sachdanandam P. Energy-modulating vitamins-a new combinatorial therapy prevents cancer cachexia in rat mammary carcinoma. British Journal of Nutrition 2005; 93: 901-909.
77. Mukherjee S, Koner BC, Ray S, Ray A. Environmental contaminants in pathogenesis of breast cancer. Ind J Exp Biol 2006; 44: 597-617.
78. Gowtham kumar S, Langeswaran K, Revathy R, Ramakrishnan V. Ethanolic extract of Carum carvi (EECC) prevents N-Nitrosodiethylamine induced phenobarbital promoted hepatocarcinogenesis by modulating antioxidant enzymes. Int J Pharm Pharm Sci 2013; 4(Suppl 1): 195-199.
79. Mathivadhani P, Shanthi P, Sachdanandam P. Effect of Semecarpus anacardium Linn. nut extract on mammary and hepatic expression of xenobiotic enzymes in DMBA-induced mammary carcinoma. Environ Toxicol Pharmacol 2007; 23: 328-34.
80. King RS, Teitel CH, Shaddock JG, Casciano DA, Kadlubar FF. Detoxification of carcinogenic aromatic and heterocyclic amines by enzymatic reduction of the N-hydroxy derivative. Cancer Lett 1999; 143(2): 167-71.
81. Sato K. Glutathione s-transferase as markers of preneoplasia and neoplalsia. Adv Cancer Res 1989; 52: 205-255.
82. Oakley A. Glutathione transferases: a structural perspective. Drug Metab Rev 2011; 43(2): 138-51.
83. Mulder GJ, Coughty MWH, Burchell B. Glucuronidation. In: Mulder GJ, editor. Conjugation reactions in drug metabolism; an intergrated approach. London, Taylor and Francis, 1990. p. 51-105.
84. Letelier ME, Pimentel A, Pino P, Lepe AM, Faúndez M, Aracena P, Speisky H. Microsomal UDP-glucuronyltransferase in rat liver: oxidative activation. Basic Clin Pharmacol Toxicol 2005; 96(6): 480-6.